A Placebo-Controlled Add-On Trial of the Ampakine, CX516, for Cognitive Deficits in Schizophrenia

AMPA-receptor-positive modulators (Ampakines) facilitate learning and memory in animal models and in preliminary trials in human subjects. CX516 is the first Ampakine to be studied for cognitive enhancement in schizophrenia. Stable schizophrenia patients treated with clozapine (n=52), olanzapine (n=...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Goff, Donald C, Lamberti, Steven, Leon, Andrew C, Green, Michael F, Miller, Alexander L, Patel, Jayendra, Manschreck, Theo, Freudenreich, Oliver, Johnson, Steven A
Formato: Artigo
Idioma:Inglês
Publicado em: 2007
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3098468/
https://ncbi.nlm.nih.gov/pubmed/17487227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.npp.1301444
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados